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Dear Editor, 
In a recent cohort-study, Pearce et al evaluated the potential association between chronic infections 
and stroke. Serological evidence of prior infection was categorized based on immunoglobulin G to 
cytomegalovirus, hepatitis A virus, hepatitis B virus, Toxoplasma gondii, and Toxocara spp. The 
positive association was significant among patients aged 20-59 years (p = 0.005) (1).  
Helicobacter pylori (H. pylori) infection is a chronic one, acquired during childhood as a rule. The 
habitat of the bacterium is the stomach, where it is the major causal factor of several gastroduodenal 
diseases (2). Moreover, H. pylori has been involved in diverse extragastric manifestations, including 
cardiovascular disease (3) and stroke (4).  
This microorganism could be a model to understand how an infectious agent could act in the 
pathogenesis of thrombosis in case of stroke.  
While atherosclerosis is an inflammatory disease in which immune mechanisms interact with 
metabolic factors to initiate, propagate, and activate lesions in the arterial tree, endothelial 
dysfunction is an early key event in the onset of acute events (5). H. pylori genomic material has 
been detected in the plaque of atherosclerosis only in sporadic occasions. Therefore, the hypothesis 
of an indirect pathway has been raised. Indeed, the long-term inflammation generated by H. pylori 
might raise cytokine levels in the bloodstream, and consequently, activate fibroblast and smooth 
muscle cell proliferation. Some study has shown that H. pylori binds von Willebrand factor and 
interacts with glycoprotein Ib to induce platelet aggregation (3). Its glycoproteins Ib and IIb/IIIa 
engage surface molecules on the endothelium cell, which may contribute to endothelial activation 
(5).  
Because stroke is the outcome of a multiplicity of factors and processes (6), complete understanding 
of causation is difficult.  
Considering the interesting findings reported by Pearce et al (1), prospective population-based 
studies should be performed in order to provide support for a causal relationship.  
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